Status:
COMPLETED
TARDIS - Photo Elicitation and Intervention
Lead Sponsor:
VA Office of Research and Development
Conditions:
Diabetes Mellitus, Type II
Type 2 Diabetes
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Veterans with type 2 diabetes (T2D) may become overwhelmed with the self-management behaviors needed to maintain optimal health. Veterans may experience diabetes distress (DD), a concept distinct from...
Detailed Description
Background and Significance: An estimated 20-25% of Veterans are diagnosed with diabetes, an incidence three times higher than the national rate. Treatment and management of poorly self-managed diabet...
Eligibility Criteria
Inclusion
- Diagnosis of type 2 diabetes (ICD-10 codes: E11.9, E11.8)
- Documentation of HbA1c drawn within the past 180 days
- Able to speak and read English
- Be able to provide informed consent to participate in the study
- Own a mobile phone with advanced computing capabilities (otherwise known as a smartphone) or mobile device to take photos (Aim 3a only)
- hemoglobin A1C (HbA1C) test value greater than or equal to 8.5 (Aim 3b only)
- Be prescribed insulin (Aim 3b only)
Exclusion
- New diagnosis of T2D within the last 60 days
- Hospitalization for mental illness within the past 30 days
- Receiving active chemotherapy and/or radiation treatment
- Diagnosis for metastatic cancer
- Recent hospitalization within the past 60 days that would influence their diabetes medication regimen (e.g., myocardial infarction, cerebrovascular accident, coronary artery bypass grafting, etc.)
- Currently receiving kidney dialysis
- Limited hearing or speech difficulties that influence the Veteran's ability to complete the survey and intervention
- Dementia, delirium, or other cognition issues that influence the Veteran's ability to provide consent and complete the survey
- Not currently prescribed insulin (Aim 3b only)
Key Trial Info
Start Date :
March 8 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2025
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT06972251
Start Date
March 8 2022
End Date
March 31 2025
Last Update
October 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Durham VA Medical Center, Durham, NC
Durham, North Carolina, United States, 27705-3875